Maternal Medications and Human Milk Research Center (M2HMRC)
Funding Amount
$2,500,000 total
Deadline
Forecast — dates not yet posted
Number of Awards
1
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- State governments
- Small businesses
- School districts
- Public colleges & universities
- For-profit businesses
- Special district governments
- Nonprofits (501(c)(3))
- Nonprofits without 501(c)(3) status
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
Overview
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to establish a Maternal Medication and Human Milk Research Center (M2HMRC) as part of the NICHD’s Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub. The M2HMRC will advance research on how maternal medications affect human milk composition and neonatal/infant health outcomes by: (1) Identifying critical knowledge gaps in medication use during pregnancy and lactation; (2) Integrating real-world evidence with chemical and bioanalytic data; (3) Developing innovative tools to improve medication safety and efficacy; and (4) Disseminating knowledge around medication use during lactation to a broad audience. The Center will collaborate with MPRINT’s Knowledge and Research Coordinating Center (KRCC) to conduct cutting-edge clinical, translational, and data science research. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will support cooperative agreements involving large-scale research activities with complex structures. Grant authorities that allow the Eunice Kennedy Shriver National Institute of Child Health and Human Development to forecast this opportunity are as follows: Public Health Service Act, Section 301, 448 and 487, as amended, Public Laws 78-410 and 99-158, as amended, 42 U.S.C. 241; 42 U.S.C. 285g; 42 U.S.C. 288; Small Business Research and Development Enhancement Act of 1992, Public Law 102-564, Public Law 118-47.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: RFA-HD-26-010
- Total Funding: $2,500,000
- Expected Awards: 1
- Instrument: cooperative_agreement
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
Focus Areas & Funding Uses
Fields of Work
- Science research
- Reproductive health
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional)
National Institutes of Health
Amount
$3,000,000 total
Deadline
October 15, 2026
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $300,000
Deadline
October 16, 2026
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
Amount
$50K – $600K
Deadline
October 19, 2026
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 19, 2026
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
Amount
$2,900,000 total
Deadline
October 19, 2026
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
Amount
$50K – $600K
Deadline
October 19, 2026
Ready to apply for Maternal Medications and Human Milk Research Center (M2HMRC)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Maternal Medications and Human Milk Research Center (M2HMRC). Now let's win it.